# Fosaprepitant

NDC: 0591-4385
Generic name: fosaprepitant
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190919

FDA application: NDA210064

## Active ingredients

- FOSAPREPITANT DIMEGLUMINE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-4385"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-4385
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9dbd4c29-d894-4839-9b22-a2f65c8c8ad1